Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR
暂无分享,去创建一个
Albert J Sinusas | Edward J Miller | A. Sinusas | Yi-Hwa Liu | E. Miller | R. Lampert | Yi-Hwa Liu | Taraneh Hashemi Zonouz | Verónica Sandoval | R. Alvi | Noor Tariq | Rachel Lampert | Raza Alvi | Veronica Sandoval | Noor Tariq
[1] L. Brewster,et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.
[2] D. Zipes,et al. Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. , 1987, Circulation.
[3] T. Nakata,et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[4] M. Cerqueira,et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[5] W. Burchert,et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[6] H. Halperin,et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. , 2008, Journal of the American College of Cardiology.
[7] Jeroen J. Bax,et al. 123I-mIBG Scintigraphy to Predict Inducibility of Ventricular Arrhythmias on Cardiac Electrophysiology Testing: A Prospective Multicenter Pilot Study , 2008, Circulation. Cardiovascular imaging.
[8] N. Roth,et al. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (123I-MIBG/99mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[9] G. Breithardt,et al. Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[10] I. Clements,et al. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT , 2016, Journal of Nuclear Cardiology.
[11] Takashi Morita,et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.
[12] D. Le Guludec,et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[13] H. Verberne,et al. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[14] M. Henzlova,et al. Assessment of 123I-mIBG and 99mTc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: Intermediate severity innervation defects are associated with higher arrhythmic risk , 2017, Journal of Nuclear Cardiology.
[15] K. Nakajima,et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[16] P. Merlet,et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] T. Nakata,et al. Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function , 2008, Journal of Nuclear Medicine.
[18] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[19] M. Cerqueira,et al. A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.
[20] G. Schmidt,et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. , 2004, European heart journal.
[21] Kevin F Kennedy,et al. CME quiz & registration form , 2014, Journal of Nuclear Cardiology.
[22] T. Nakata,et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. , 2013, JACC. Cardiovascular imaging.
[23] T. Nakata,et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[24] D. Zipes,et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. , 1988, Circulation.
[25] K. Nakajima,et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[26] Jeroen J. Bax,et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. , 2010, Journal of the American College of Cardiology.
[27] B. van Eck-Smit,et al. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[28] I. Carrió,et al. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[29] A. de Roos,et al. Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions , 2012, Journal of Nuclear Cardiology.
[30] M. Stanton,et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. , 1989, Journal of the American College of Cardiology.
[31] M. Akers,et al. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. , 1991, The American journal of cardiology.